Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Z-350, a novel treatment for BPH with a dual mechanism of action

July 21, 1999

Potential new diuretic agents selected for detailed biological evaluation at Wakamoto

July 16, 1999

Recently issued patent covers Sanofi-Synthelabo's new M3 antagonists

July 16, 1999

Nephrin plays a key role in kidney filtration

July 16, 1999

Potassium channel openers in development at Abbott for various medical conditions

July 15, 1999

Potent, orally active AVP receptor antagonist increases urine output in rats

July 14, 1999

KRP-197: new bladder-selective antimuscarinic agent in clinical trials for bladder dysfunction

July 14, 1999

Two more European countries permit phase II studies of resiniferatoxin

July 8, 1999

Uroselective alpha-adrenoceptor blocker GYKI-16084 assessed in BPH and spinal cord injury models

July 7, 1999

Angiotensin II blockade as a strategy for preventing renal allograft nephropathy

July 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...